Search

for
Search:

Products matching "minoxidil oral"

Tracking 20 products like 137 Minoxidil oral, 40 Oral Minoxidil, 13 Lonitab 10 mg, 250 Minoxidil 90 caps and 19 Minoxidil+supplement Blend from by companies like Manual, Roman, AllDayChemist, MV supplements and Hims. View all 20 products »

Sort by

Research

270-300 / 1000+ results

Safety and Tolerability of Low Dose Oral Minoxidil Monotherapy in Female Pattern Hair Loss: A Retrospective Review With Longitudinal Ambulatory Blood Pressure Monitoring

research Safety and tolerability of low dose oral minoxidil monotherapy in female pattern hair loss: A retrospective review with longitudinal ambulatory blood pressure monitoring

August 2023 in “JAAD International”

Low dose oral minoxidil is generally safe and can improve hair loss in women, with some experiencing side effects and minimal blood pressure changes.

research In Brief: Oral minoxidil for hair loss.

December 2022 in “PubMed”

research Effects of oral minoxidil on nails: a cross‐sectional analysis

February 2023 in “International Journal of Dermatology”

research Low‐dose oral minoxidil in female patients with lichen planopilaris: Real‐life experience

August 2022 in “Journal of The European Academy of Dermatology and Venereology”

research Minoxidil induced central serous Chorioretinopathy treated with oral Eplerenone – a case report

4 citations , June 2020 in “BMC Ophthalmology”

Minoxidil can cause a rare eye condition, but it was successfully treated with oral Eplerenone in one case.

research A randomised trial of 5% minoxidil versus combination of 5% minoxidil and oral spironolactone in treatment of female pattern hair loss

October 2019 in “International Journal of Research in Dermatology”

Combining minoxidil and spironolactone is more effective for female hair loss, but minoxidil alone is sufficient after 6 months.

research No association between low-dose oral minoxidil and pericardial effusion in a large retrospective cohort study of nonscarring alopecia patients

1 citations , February 2025 in “Journal of the American Academy of Dermatology”

research Is There a Place for Oral Minoxidil? An Overview

1 citations , January 2010

research 0478 Outcomes of oral dutasteride and oral minoxidil for treating endocrine therapy-induced alopecia from breast cancer treatment: A case series

July 2025 in “Journal of Investigative Dermatology”

research Use of low-dose oral minoxidil for hair growth in transgender and gender non-binary adult patients: a retrospective cohort study

June 2025 in “Journal of the American Academy of Dermatology”

research Response to “Low-dose oral minoxidil for androgenetic alopecia is not associated with clinically significant blood-pressure changes: a retrospective study”

March 2024 in “Journal of the American Academy of Dermatology”

research BH16: Trichorrhexis nodosa improving with oral minoxidil: a case report

July 2022 in “British Journal of Dermatology”

research Adverse Effects of Low-dose Oral Minoxidil for Androgenetic Alopecia in 435 patients – Supplemental material

November 2020

research Comparative study between topical minoxidil 5% and oral spironolactone versus topical minoxidil 5% and oral dutasteride in the treatment of women with androgenic alopecia

June 2026 in “International Journal of Medical Arts”

Metabolism of Minoxidil, a New Hypotensive Agent: Biotransformation Following Oral Administration to Rats, Dogs, and Monkeys

research Metabolism of Minoxidil, a New Hypotensive Agent 11: Biotransformation following Oral Administration to Rats, Dogs, and Monkeys

31 citations , August 1975 in “Journal of Pharmaceutical Sciences”

Minoxidil metabolizes similarly in monkeys and humans, but differently in dogs and rats.

research 77034 Efficacy and safety outcomes of oral minoxidil versus topical minoxidil in patients undergoing follicle unit extraction

July 2026 in “Journal of the American Academy of Dermatology”

Placebo-Controlled Dose-Effect Studies with Topical Minoxidil 2% or 5% in Male-Patterned Hair Loss Treated with Oral Finasteride Employing an Analytical and Exhaustive Study Protocol

research Placebo‐controlled dose‐effect studies with topical minoxidil 2% or 5% in male‐patterned hair loss treated with oral finasteride employing an analytical and exhaustive study protocol

5 citations , January 2020 in “Skin Research and Technology”

Minoxidil 5% works better than 2% for hair growth in male-patterned hair loss.

research Orthostatic symptoms in women treated with low-dose oral minoxidil in the absence of overt hypotension: Implications for clinical practice

2 citations , June 2025 in “Journal of the American Academy of Dermatology”

research Efficacy and Safety of Oral Dutasteride 0.5 mg Combined with Oral Minoxidil 2.5 mg for Male Androgenetic Alopecia: A Retrospective Cohort Study

July 2026 in “Research Square”

research Gray Hair Repigmentation in Androgenetic Alopecia Under Oral Minoxidil

April 2026 in “International Journal of Dermatology”

research Time to Maximal Response with Low-Dose Oral Minoxidil in Clinical Treatment of Androgenetic Alopecia

April 2026 in “Journal of the American Academy of Dermatology”

research Faculty Opinions recommendation of Safety of low-dose oral minoxidil for hair loss: A multicenter study of 1404 patients.

May 2021 in “Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature”

research Faculty Opinions recommendation of Safety of low-dose oral minoxidil for hair loss: A multicenter study of 1404 patients.

July 2021 in “Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature”

research Acute Encephalomyelitis Syndromes Associated with H1N1 Influenza Vaccinations; Erythema Multiforme Secondary to H1N1 Vaccine; Cytolytic Hepatitis Possibly Related to Oral Contraceptives; Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) Syndrome Associated with Lamotrigine: First Report; Behavioral Disinhibition with Baclofen; Minoxidil-Induced Trichostasis Spinulosa of Terminal Hair; Delayed-Onset Mirtazapine-Related Leukopenia

1 citations , March 2011 in “Hospital Pharmacy”

Various medications and vaccines can cause serious side effects.

research Supplementary Materials for Safety and tolerability of combination oral spironolactone and low-dose oral minoxidil for hair loss in adult females: A retrospective cohort study

January 2026 in “Mendeley Data”

research Supplementary Materials for Safety and tolerability of combination oral spironolactone and low-dose oral minoxidil for hair loss in adult females: A retrospective cohort study

January 2026 in “Mendeley Data”

research Effectiveness of Topical Minoxidil (5%) Plus Topical Finasteride (0.1%) Fixed-Dose Combination Versus Topical Minoxidil (5%) Plus Oral Finasteride (1 Mg/Day) in Grade II-IV Androgenetic Alopecia: A Randomized, Double Blind Clinical Trial

January 2021 in “Asian Journal of Research in Dermatological Science”

research 76221 Faster Onset and Superior Efficacy of an Investigational Extended-Release Oral Minoxidil Tablet (VDPHL01) Versus Topical and Immediate-Release Oral Minoxidil for Androgenetic Alopecia: Results from a Blinded Retrospective Investigator Global Assessment

July 2026 in “Journal of the American Academy of Dermatology”

research Supplemental Figure 1 for "Time to Maximal Response with Low-Dose Oral Minoxidil in Clinical Treatment of Androgenetic Alopecia"

April 2026 in “Mendeley Data”

research Supplemental Figure 1 for "Time to Maximal Response with Low-Dose Oral Minoxidil in Clinical Treatment of Androgenetic Alopecia"

April 2026 in “Mendeley Data”

← Previous page Next page →